{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:23:16Z","timestamp":1759040596009},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/mjt.0b013e31828e5d0b","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T16:49:22Z","timestamp":1368636562000},"page":"e218-e220","source":"Crossref","is-referenced-by-count":3,"title":["Low-Dose Manic Switch and High-Dose Antimanic Effect and Extrapyramidal Symptoms by Aripiprazole in a Single Bipolar Patient"],"prefix":"10.1097","volume":"21","author":[{"given":"Young-Min","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210202","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1517\/14656566.2012.719876","article-title":"Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.","volume":"13","author":"de Bartolomeis","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"R2-28-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/11208320-000000000-00000","article-title":"Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.","volume":"72","author":"Dhillon","year":"2012","journal-title":"Drugs"},{"key":"R3-28-20210202","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/ajp.2007.164.1.172a","article-title":"Manic episode during treatment with aripiprazole.","volume":"164","author":"Padala","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R4-28-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2006-951609","article-title":"A case of aripiprazole-induced mania.","volume":"40","author":"Traber","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"R5-28-20210202","first-page":"37","article-title":"First manic episode in a 55-year-old man after initiation of aripiprazole.","volume":"7","author":"Donohue","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"key":"R6-28-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-0030-1268428","article-title":"Three cases of hypomania and one case of mania during aripiprazole treatment.","volume":"44","author":"Viikki","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"R7-28-20210202","first-page":"836","article-title":"Hypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: dose-related phenomenon J Clin Psychopharmacol.","volume":"32","author":"Lin","year":"2012","journal-title":""},{"key":"R8-28-20210202","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":". A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R9-28-20210202","first-page":"862","article-title":". Benzodiazepinestheir role in aggression and why GPs should prescribe with caution.","volume":"40","author":"Jones","year":"2011","journal-title":"Aust Fam Physician"},{"key":"R10-28-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(02)00317-8","article-title":"Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis.","volume":"78","author":"Curtin","year":"2004","journal-title":"J Affect Disord"},{"key":"R11-28-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","article-title":"Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex.","volume":"387","author":"Zocchi","year":"2005","journal-title":"Neurosci Lett"},{"key":"R12-28-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":". Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.","volume":"493","author":"Li","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"R13-28-20210202","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/026988110401800308","article-title":". Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile.","volume":"18","author":"Hirose","year":"2004","journal-title":"J Psychopharmacol"},{"key":"R14-28-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13651501.2011.605957","article-title":"Atypical antipsychotic-induced maniahypomania: a review of recent case reports and clinical studies.","volume":"16","author":"Benyamina","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R15-28-20210202","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.4088\/JCP.v65n1116","article-title":". Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.","volume":"65","author":"Rachid","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R16-28-20210202","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2133\/dmpk.22.358","article-title":". Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism.","volume":"22","author":"Kubo","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"R17-28-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/FTD.0b013e3182031021","article-title":". Effects of the CYP2D610 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.","volume":"33","author":"Suzuki","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R18-28-20210202","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2125.2008.03223.x","article-title":". Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.","volume":"66","author":"Kim","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R19-28-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1185\/030079903125002919","article-title":"Focus on aripiprazole.","volume":"20","author":"Green","year":"2004","journal-title":"Curr Med Res Opin"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e31828e5d0b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:54Z","timestamp":1620963474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201411000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31828e5d0b","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}